JTH will no longer have an active presence on X. While this account will remain available as an archive, we will no longer monitor comments or post new content.
Joined November 2016
- Tweets7.7K
- Following6.8K
- Followers9.4K
- Likes1.7K
JTH retweeted
The Repeat Study addressed a really important knowledge gap!
The incidence of recurrent events following an ante- or postpartum VTE is 2.4% person-years. The cumulative risks are 6%, 13%, 17%, and 30% at 2, 5, 10, and 30 years respectively.
jthjournal.org/article/S1538…
ALT Cumulative risk of recurrent VTE
JTH retweeted
🚨How to deal with interference on heparin anti-Xa activity caused by oral factor FXa inhibitors: Communication from the @isth SSC Subcommittee on Control of Anticoagulation @JTHjournal
🙏 Great team work with @CukerMd @LanaCastellucci @thachil
jthjournal.org/article/S1538…
JTH retweeted
📰How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant👉 pubmed.ncbi.nlm.nih.gov/3993…, publicado en @JTHjournal
Nuestros compañeros C. Bravo y J. Corral @IMIB_RMurcia @CIBERER y @Catedra_Hemato junto a colegas de universidades de Bruselas🇧🇪Johns Hopkins🇺🇸y Debrecen🇭🇺aportan experiencia personal en el tratamiento de deficiencia en homocigosis de antitrombina pubmed.ncbi.nlm.nih.gov/3993…
JTH retweeted
Preventing arterial #thromboembolism (ATE) in high-risk cancer patients should focus on modifiable CV risk factors. Kim et al.'s study explores the link between cancer, CV risk factors, and ATE. @JTHjournal. authors.elsevier.com/a/1kh7B…
JTH retweeted
Interested in the fundamentals of key topics in #thrombosis and #hemoastasis?
Don't miss the BRAND NEW Educational Review Series in @isth @JTHjournal
Check it out 👇
Big news from @JTHjournal: a NEW Educational Review Series designed to break down the fundamentals of key topics in thrombosis & hemostasis!🔬
These reviews are must-read resources for clinicians, researchers & healthcare professionals. Learn more here: bit.ly/3EAaVNZ
JTH retweeted
🔴Venous thromboembolism and Duration of Anticoagulation ⤵️ #2025Review @JTHjournal
🔹Basics of diagnosis and treatment of venous thromboembolism
🔹Category of Major persistent risk factor, requiring long term anticoagulation.
🔹Learn more here: bit.ly/3EAaVNZ
JTH retweeted
Something we really needed! Comprehensive and understandable review which can be useful to all early career professionals. Thanks to @JTHjournal for this educational review series. Looking forward to the next one jthjournal.org/article/S1538…
JTH retweeted
🚨#BloodClotAwarenessMonth is almost here!🚨
We're dedicated to shining a light on thrombosis through the award-winning #WorldThrombosisDay campaign. This year, we’re bringing you a @RPTHjournal Research Recap on "Health Literacy in Pediatric Thrombosis: A Landscape Analysis."
Don’t miss this discussion: streamyard.com/watch/XPBubvR…
JTH retweeted
Big news from @JTHjournal: a NEW Educational Review Series designed to break down the fundamentals of key topics in thrombosis & hemostasis!🔬
These reviews are must-read resources for clinicians, researchers & healthcare professionals. Learn more here: bit.ly/3EAaVNZ
JTH retweeted
Useful figure for counselling patients about risk of recurrent thrombosis and for considering anticoagulation duration
@richardbuka @JTHjournal @RazaSN
⭐️ VTE And duration of anticoagulation
Category of Major persistent risk factor, requiring long term anticoagulation.
@JTHjournal Review article describes various nuances of anticoagulation.
JTH retweeted
⭐️ VTE And duration of anticoagulation
Category of Major persistent risk factor, requiring long term anticoagulation.
@JTHjournal Review article describes various nuances of anticoagulation.
Big news from @JTHjournal: a NEW Educational Review Series designed to break down the fundamentals of key topics in thrombosis & hemostasis!🔬
These reviews are must-read resources for clinicians, researchers & healthcare professionals. Learn more here: bit.ly/3EAaVNZ
JTH retweeted
🚨Good News! 🚨 Our groundbreaking study by @EAndraska, @macky_neal, and team published @JTHjournal is making waves! Dive into the findings that are sparking major interest. Read more here: 👇👇👇
tinyurl.com/3xwtuttr
@PittHealthSci @UPMC @DeptofDefense @NIGMS
@nih_nhlbi
JTH retweeted
💡Don't miss the next @ISTH #SSC on the Case on Pediatric and Neonatal #Thrombosis and #Hemostasis: CSVT and Mesenteric Vein Thrombosis with MIS-C
🎙️Presenters: Julia David 🇺🇸 & Christy Mak 🇭🇰
🗓️February 10th, 2025 from 16:00 – 17:00 UTC
👉bit.ly/3E1N4Gw
JTH retweeted
The February edition of the ISTH Congress Chronicle is here! We’re just 4 months away from #ISTH2025 and this latest edition is packed with must-know details to help you prepare from our ACPC chair @GuyYoungMD, including:
✅Key travel and accommodation tips
✅A brand-new session format: Special Sessions
✅Exciting opportunities for Early Career professionals
Read the full edition and stay ahead of all the Congress updates: isth2025.org/congresschronic…
Don't wait—register, book your hotel, and get ready for an incredible ISTH 2025! See you in D.C.!✨
JTH retweeted
Females with hemophilia: From "silent carriers" ➡️recognized patients with real bleeding risks.
Decades of evidence ignored, but change is happening!
An excellent historical sketch of evolving beliefs & practices. doi.org/10.1016/j.jtha.2024.…
@JTHjournal #WomensHealth #ClassicalHem
JTH retweeted
Excited to share our latest publication @JTHjournal 🤩, titled 'Fibrin film on clots is increased by hematocrit but reduced by inflammation: implications for platelets and fibrinolysis’
doi.org/10.1016/j.jtha.2024.…
JTH retweeted
📣 HAPPENING NOW! Join us here: bit.ly/3PPjg2N
Kick off 2025 with cutting-edge insights ✂️! Join us TODAY for the first ISTH webinar of the year on anticoagulation in chronic kidney disease. Explore: 📷Common hemostatic challenges in patients w/ chronic kidney disease 📷bit.ly/3PPjg2N
JTH retweeted
Great to share our new paper in
@JTHjournal - Fibrin film on clots is increased by hematocrit but reduced by inflammation: implications for platelets and fibrinolysis jthjournal.org/article/S1538…
@RobertAriens @CedricDuval22 #fibrinogen #thrombosis #hemostasis #inflammation
JTH retweeted
How to distinguish amongst these two? Continues to be a very challenging setting since so many clinical overlaps exist. Super helpful review by @JTHjournal! #LatinainHeme #Hemefan 🔥
How do we distinguish DIC vs. cirrhotic coagulopathy?
A new ISTH SSC communication reviewed the overlap and distinctions between disseminated intravascular coagulation (DIC) and cirrhotic coagulopathy in patients with cirrhosis.
#DIC #platelet #cirrhosis
sciencedirect.com/science/ar…
JTH retweeted
🔬Alterations in visible #light exposure modulate #platelet function and regulate #thrombus formation 👉jthjournal.org/article/S1538…, publicado en @JTHjournal
